31 agosto 2015
HIV-1 infection with multiple founder variants points to poorer clinical outcomes than infection with a single variant, according to research. In the study, researchers analyzed large sample sets from two important HIV vaccine efficacy trials — the Step HIV vaccine clinical trial (HVTN 502) and RV144, the landmark vaccine clinical trial conducted in Thailand — to evaluate whether genetic characteristics of the founder viral populations could influence markers of clinical outcomes.
http://www.sciencedaily.com/releases/2015/08/150831123219.htm
